Cargando…
Differential Integration of Transcriptome and Proteome Identifies Pan-Cancer Prognostic Biomarkers
High-throughput analysis of the transcriptome and proteome individually are used to interrogate complex oncogenic processes in cancer. However, an outstanding challenge is how to combine these complementary, yet partially disparate data sources to accurately identify tumor-specific gene products and...
Autores principales: | Schwartz, Gregory W., Petrovic, Jelena, Zhou, Yeqiao, Faryabi, Robert B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6018483/ https://www.ncbi.nlm.nih.gov/pubmed/29971090 http://dx.doi.org/10.3389/fgene.2018.00205 |
Ejemplares similares
-
TooManyPeaks identifies drug-resistant-specific regulatory elements from single-cell leukemic epigenomes
por: Schwartz, Gregory W., et al.
Publicado: (2021) -
TooManyCells identifies and visualizes relationships of single-cell clades
por: Schwartz, Gregory W., et al.
Publicado: (2020) -
Transcriptome and pan-cancer system analysis identify PM2.5-induced stanniocalcin 2 as a potential prognostic and immunological biomarker for cancers
por: Zhu, Dong, et al.
Publicado: (2023) -
Integrated pan-cancer analysis of CSMD2 as a potential prognostic, diagnostic, and immune biomarker
por: Zhang, Huiyun, et al.
Publicado: (2022) -
Pan-cancer analyses reveal IGSF10 as an immunological and prognostic biomarker
por: Zhou, Yongxia, et al.
Publicado: (2023)